je.st
news
Tag: collaboration
Ceres and Raízen sign multi-year collaboration to scale-up sweet sorghum for ethanol in Brazil
2015-03-16 15:55:32| Green Car Congress
Artes Biotechnology Announces Collaboration with Boehringer Ingelheim
2015-03-16 01:00:00| ThePigSite - Industry News
GERMANY - ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health.
Tags: collaboration
announces
artes
biotechnology
ABB to Showcase "New Era of Robotics" Built on the Pillars of Collaboration, Simplification and Integration at Automate 2015
2015-03-12 11:31:11| Industrial Newsroom - All News for Today
Demos include advanced systems for small parts assembly, laser welding, high speed picking, customer service and operational software AUBURN HILLS, Mich. ABB Robotics will showcase "A New Era of Robotics" built upon the three pillars of collaboration, simplification and integration at Automate 2015, March 23-26...
Tags: built
era
collaboration
integration
OIE and Centers for Disease Control and Prevention Reinforce Collaboration
2015-03-11 01:00:00| ThePigSite - Industry News
US - The meetings with Dr Frieden, CDC Director, and senior staff representatives provided the opportunity to reaffirm several key topics of common interest in order to pursue and strengthen efficient cooperation between the two organisations.
Tags: control
disease
collaboration
centers
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy with Multi-targeting RTK Inhibitor and Microtubule Dynamics Inhibitor in Multiple Types of Cancer
2015-03-05 00:30:00| Merck.com - Product News
Dateline City: TOKYO & KENILWORTH, N.J. Combination clinical studies of lenvatinib, eribulin and pembrolizumab to be explored TOKYO & KENILWORTH, N.J.--(BUSINESS WIRE)--Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Mercks anti-PD-1 therapy, pembrolizumab (marketed in the U.S. under the brand name KEYTRUDA), in combination with Eisai oncology compounds lenvatinib mesylate (a multi-targeting RTK inhibitor marketed in the U.S. Language: English Contact: Eisai Public Relations Department+81-(0)3-3817-5120orEisai Investor Relations+81-(0)3-3817-5327orMerck Media RelationsPamela Eisele, 267-305-3558or Claire Mulhearn, 908-236-1118orMerck Investor RelationsJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] next »